Basics Instil Bio, Inc. IPO Date: March 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $156.59M Activated in VL: True Average Daily Range Avg Daily Range: $0.68 | 4.33% Avg Daily Range (30 D): $1.71 | 6.19% Avg Daily Range (90 D): $1.48 | 6.77% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): .28M Avg Daily Volume (90 D): .22M Trade Size Avg Trade Size (Sh.): 105 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 191 Avg Inst. Trade: $2.22M Avg Inst. Trade (30 D): $1.16M Avg Inst. Trade (90 D): $1M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.01M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.1M Avg Closing Volume: 36.51K     News Jul 7, 2025 @ 5:00 PM Bispecific Antibody Clinical Trial Pipeline Gains ... Source: Delveinsight Jun 11, 2025 @ 11:00 AM Instil Bio Names John Maraganore, Ph.D., to Board ... Source: N/A May 22, 2025 @ 10:00 AM Instil Bio and ImmuneOnco Announced the Phase 2 Tr... Source: N/A May 13, 2025 @ 11:00 AM Instil Bio Reports First Quarter 2025 Financial Re... Source: N/A Apr 1, 2025 @ 6:44 PM Tumor-infiltrating Lymphocyte (TIL) Therapies Glob... Source: Researchandmarkets.Com Financials   TTM Q1 2025 Q4 2024 Basic EPS $-11.97 $-4.32 $-1.82 Diluted EPS $-11.97 $-4.32 $-1.82 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -78.03M $ -28.2M $ -11.9M Operating Income / Loss $ -80.15M $ -30.56M $ -11.82M Cost of Revenue $ $ $ Net Cash Flow $ 5.57M $ 5.69M $ 3.97M PE Ratio     Splits Dec 08, 2023:   1:20